Featured Research

from universities, journals, and other organizations

FDA review on transgenic salmon too narrow, experts say

Date:
November 19, 2010
Source:
Duke University
Summary:
The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to new analysis.

An Atlantic Salmon leaping a set of rapids. The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production.
Credit: iStockphoto/Lee Sutterby

The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to analysis by a Duke University-led team in the journal Science.

The salmon, whose genome contains inserted genes from two other fish species, could become the first genetically modified animal approved for human consumption in the United States.

The FDA held two days of hearings in September to assess the fish's human and environmental health risks. The period for public comment ends this month. A final FDA decision could be imminent.

The concern, Duke economist Martin D. Smith says, is that the new animal drug application process FDA is using to review the transgenic salmon evaluates its safety only by comparing its nutritional profile to an equivalent portion of nonmodified salmon, and screening it for known toxins and allergens.

Smith said such a process ignores the potential health and environmental effects of salmon production and consumption -- both positive and negative -- that might stem from the fish's faster growth and less need for feed.

"These market impacts could dwarf any small differences in nutritional content," says Smith, associate professor of environmental economics at Duke's Nicholas School of the Environment.

A smarter approach, Smith and his coauthors argue, would be for FDA -- or if necessary, Congress -- to broaden the interpretation of the terms "safe" and "health" in FDA statutes so its review process can include an evaluation of the overall safety of the new fish compared to other protein sources that it might replace, such as beef.

"Instead of focusing on the safety of a food taken one portion at a time or whether it was produced through genetic modifications or through classic breeding, a more useful approach would be to evaluate whether society is better off overall with the new product on the market than without it," says Jonathan B. Wiener, William R. and Thomas L. Perkins Professor of Law at Duke Law School.

This fuller assessment would require FDA regulators to take into consideration factors currently unaccounted for, such as public health impacts that could occur if, as is likely, increased production of transgenic farmed salmon leads to lower retail prices and increased consumption.

"Lower prices for salmon would have significant public health benefits," Smith explained. "Consumers would have access to a less expensive source of healthy protein and omega-3 fatty acids, which have well-documented health benefits."

A broader review would also allow a fuller assessment of potential environmental impacts, such as pollution from farmed salmon waste; disease; increased harvesting of the wild fish used to feed farmed salmon; and the escape of genetically modified salmon into the wild, where they could affect wild salmon stocks through gene transfer or increased competition for resources.

The National Environmental Policy Act mandates FDA to assess significant environmental impacts from market expansion of the products it approves, yet the narrow scope of the current review process for new animal drugs presents "an incomplete picture" of these risks and benefits for transgenic salmon, the researchers write in their analysis.

"The approval of genetically modified salmon will set an important precedent for other transgenic animals intended for human consumption," Smith says. "It's essential that FDA establishes an approval process that assesses the full portfolio of impacts to ensure that such decisions serve society's best interests." FDA administrators need to weigh the benefits of such assessments against the costs and delays they likely would incur, he says.

If conducting a full assessment of transgenic salmon would take too long, a reasonable compromise would be to use existing studies to develop scenarios of market growth and the broader impacts to human and environmental health that may occur as a result.

Frank Asche of the University of Stavanger, Norway, and Atle G. Guttormsen of the Norwegian University of Life Sciences co-authored the Science paper with Smith and Wiener.


Story Source:

The above story is based on materials provided by Duke University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Smith, et al. Genetically Modified Salmon and Full Impact Assessment. Science, 19 November 2010: 1052-1053. DOI: 10.1126/science.1197769

Cite This Page:

Duke University. "FDA review on transgenic salmon too narrow, experts say." ScienceDaily. ScienceDaily, 19 November 2010. <www.sciencedaily.com/releases/2010/11/101118141539.htm>.
Duke University. (2010, November 19). FDA review on transgenic salmon too narrow, experts say. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2010/11/101118141539.htm
Duke University. "FDA review on transgenic salmon too narrow, experts say." ScienceDaily. www.sciencedaily.com/releases/2010/11/101118141539.htm (accessed August 20, 2014).

Share This




More Plants & Animals News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Awesome New Camouflage Sheet Was Inspired By Octopus Skin

Awesome New Camouflage Sheet Was Inspired By Octopus Skin

Newsy (Aug. 19, 2014) Scientists have developed a new device that mimics the way octopuses blend in with their surroundings to hide from dangerous predators. Video provided by Newsy
Powered by NewsLook.com
Disquieting Times for Malaysia's 'fish Listeners'

Disquieting Times for Malaysia's 'fish Listeners'

AFP (Aug. 19, 2014) Malaysia's last "fish listeners" -- practitioners of a dying local art of listening underwater to locate their quarry -- try to keep the ancient technique alive in the face of industrial trawling and the depletion of stocks. Duration: 02:29 Video provided by AFP
Powered by NewsLook.com
USDA Cracks Down On Imports From Foreign Puppy Mills

USDA Cracks Down On Imports From Foreign Puppy Mills

Newsy (Aug. 18, 2014) New USDA measures to regulate dog imports aim to crack down on buying dogs from overseas puppy mills. Video provided by Newsy
Powered by NewsLook.com
Bone Marrow Drug Regrows Hair In Some Alopecia Patients

Bone Marrow Drug Regrows Hair In Some Alopecia Patients

Newsy (Aug. 18, 2014) Researchers performed an experiment using an FDA-approved drug known as ruxolitinib. They found it to be successful in the majority of patients. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins